相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Prognostic value of indoleamine 2,3 dioxygenase in patients with higher-risk myelodysplastic syndromes treated with azacytidine
Catharina Mueller-Thomas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Efficacy and predictive factors of venetoclax combined with azacitidine as salvage therapy in advanced acute myeloid leukemia patients: A multicenter retrospective study
Yinjun Lou et al.
LEUKEMIA RESEARCH (2020)
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Emir Hadzijusufovic et al.
CANCERS (2020)
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia
Abhishek A. Mangaonkar et al.
BLOOD ADVANCES (2020)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent et al.
HAEMATOLOGICA (2019)
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations
Hatice D. Gur et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer et al.
LEUKEMIA (2018)
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
Mrinal M. Patnaik et al.
LEUKEMIA (2018)
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer et al.
LEUKEMIA (2018)
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults Recommendations From the European Hematology Association and the European LeukemiaNet
Raphael Itzykson et al.
HEMASPHERE (2018)
CMML: Clinical and molecular aspects
Raphael Itzykson et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
Akihide Yoshimi et al.
BLOOD (2017)
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines
Yanyan Zhang et al.
BLOOD ADVANCES (2017)
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
Theo de Witte et al.
BLOOD (2017)
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Irina Sadovnik et al.
CLINICAL CANCER RESEARCH (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Laura Palomo et al.
ONCOTARGET (2016)
Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update
Kristen B. McCullough et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Harald Herrmann et al.
BLOOD (2014)
Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
Mrinal M. Patnaik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
P. Valent
CURRENT CANCER DRUG TARGETS (2011)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
Marcus Jaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
Yoriko Saito et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
A. Pich et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
N. Misaghian et al.
LEUKEMIA (2009)
Chronic myelogenous leukemia stem cells: What’s new?
Mhairi Copland
Current Hematologic Malignancy Reports (2009)
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
David C. Taussig et al.
BLOOD (2008)
Chronic myeloid leukemia stem cells
Edward Kavalerchik et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Right on target: eradicating leukemic stem cells
Daniela S. Krause et al.
TRENDS IN MOLECULAR MEDICINE (2007)
The novel AML stem cell-associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells
Anna van Rhenen et al.
BLOOD (2007)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease
W Eisterer et al.
LEUKEMIA (2005)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Detection of c-kit point mutation Asp-816 → Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia
K Sotlar et al.
LEUKEMIA RESEARCH (2002)
Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo
HS Ramshaw et al.
EXPERIMENTAL HEMATOLOGY (2002)
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia.: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis
WR Sperr et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
分享论文
